Yang Yuanheng, Liu Yuwei, Lin Zixuan, Shen He, Lucas Caitlin, Kuang Biao, Tuan Rocky S, Lin Hang
Center for Cellular and Molecular Engineering, Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, 15219, USA.
Department of Plastic and Cosmetic Surgery, Department of Orthopaedic Surgery, Xiangya hospital, Central South University, Changsha, Hunan, 410008, China.
Adv Biosyst. 2019 Dec;3(12):e1900229. doi: 10.1002/adbi.201900229. Epub 2019 Nov 4.
Mesenchymal stem cells (MSCs) represent a promising cell source to regenerate injured cartilage. In this study, MSCs are cultured under confluent conditions for 10 days to optimize the deposition of the extracellular matrix (mECM), which will serve as the scaffold to support MSC chondrogenesis. Subsequently, the MSC-impregnated mECM (MSC-mECM) composite is briefly treated with trypsin, allowing the MSCs to adopt a round morphology without being detached from their own mECM. The constructs are then cultured in a chondrogenic medium. Interestingly, after trypsin removal, the treated MSCs undergo an aggregation process, mimicking mesenchymal condensation during developmental chondrogenesis, specifically indicated by peanut agglutinin staining and immunodetectable N-cadherin expression, followed by robust chondrogenic differentiation. In comparison to conventional pellet culture, chondrogenically induced MSC-mECM displays a similar level of chondrogenesis, but with significantly reduced hypertrophy. The reparative capacity of the MSC-mECM derived construct is assessed using bovine cartilage explants. Mechanical testing and histology results show that engineered cartilage from MSC-mECM forms better integration with the surrounding native cartilage tissue and displays a much lower hypertrophic differentiation than that from pellet culture. Taken together, these findings demonstrate that MSC-mECM may be an efficacious stem cell-based product for the repair of hyaline cartilage injury without the use of exogenous scaffolds.
间充质干细胞(MSCs)是一种很有前景的用于再生受损软骨的细胞来源。在本研究中,将MSCs在汇合条件下培养10天,以优化细胞外基质(mECM)的沉积,mECM将作为支持MSCs软骨形成的支架。随后,用胰蛋白酶对负载MSCs的mECM(MSC-mECM)复合物进行短暂处理,使MSCs呈现圆形形态,且不与自身的mECM分离。然后将构建体在软骨形成培养基中培养。有趣的是,去除胰蛋白酶后,处理过的MSCs会经历聚集过程,模拟发育性软骨形成过程中的间充质凝聚,花生凝集素染色和可免疫检测到的N-钙黏蛋白表达可明确显示这一过程,随后是强烈的软骨形成分化。与传统的微球培养相比,经软骨形成诱导的MSC-mECM表现出相似水平的软骨形成,但肥大程度显著降低。使用牛软骨外植体评估MSC-mECM衍生构建体的修复能力。力学测试和组织学结果表明,来自MSC-mECM的工程化软骨与周围天然软骨组织形成更好的整合,并且与微球培养的相比,其肥大分化程度低得多。综上所述,这些发现表明,MSC-mECM可能是一种有效的基于干细胞的产品,可用于修复透明软骨损伤,而无需使用外源性支架。